Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites Posted on August 23, 2022September 21, 2022 By sdargoltz Liesl K. Janssens, Simon Hudson, David M. Wood, Caitlin Wolfe, Paul I. Dargan & Christophe P. Stove Arch Tox; 2022 Access article Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology